INVESTOR AGREEMENTInvestor Agreement • February 10th, 2015 • Cloud Gate Capital, LLC • Retail-drug stores and proprietary stores • Delaware
This AGREEMENT is made and entered into as of February 6, 2015 (this “Agreement”) by and among BioScrip, Inc., a Delaware corporation (the “Company”), and each of the other parties listed on the signature pages hereto (each, an “Investor” and collectively, the “Investors”). The Company and the Investors are referred to herein as the “Parties.”
CONSENT AND AGREEMENT TO JOINT FILINGConsent and Agreement • December 30th, 2014 • Cloud Gate Capital, LLC • Retail-drug stores and proprietary stores
Pursuant to Rule 13d-1(k)(1)(iii) of Regulation 13D-G of the Rules and Regulations of the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended, each of the undersigned persons does hereby consent to and agree to jointly file with the Securities and Exchange Commission a Schedule 13D on behalf of each of them with respect to their beneficial ownership of common stock, par value $0.0001 per share, of BioScrip, Inc., and any future amendments thereto as may be required from time to time.
